Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Drosophila melanogaster
Entry Details
ID
4765
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
P35992 (Created: 1994-06-01 Updated: 2009-01-20)
UniProtKB/Swiss-Prot Entry Name
PTP10_DROME
Protein Name
Tyrosine-protein phosphatase 10D
Gene
Ptp10D
Organism Scientific
Drosophila melanogaster
Organism Common
Fruit fly
Lineage
Eukaryota
Metazoa
Arthropoda
Hexapoda
Insecta
Pterygota
Neoptera
Endopterygota
Diptera
Brachycera
Muscomorpha
Ephydroidea
Drosophilidae
Drosophila
Sophophora
Protein Length [aa]
1631
Protein Mass [Da]
185081
Features
Type
Description
Status
Start
End
signal peptide
potential
1
42
chain
Tyrosine-protein phosphatase 10D
43
1631
transmembrane region
potential
1198
1218
topological domain
Extracellular
potential
43
1197
topological domain
Cytoplasmic
potential
1219
1631
domain
Fibronectin type-III 1
43
119
domain
Fibronectin type-III 2
120
214
domain
Fibronectin type-III 3
215
308
domain
Fibronectin type-III 4
309
402
domain
Fibronectin type-III 5
403
493
domain
Fibronectin type-III 6
494
580
domain
Fibronectin type-III 7
581
669
domain
Fibronectin type-III 8
670
766
domain
Fibronectin type-III 9
767
861
domain
Fibronectin type-III 10
862
955
domain
Fibronectin type-III 11
956
1048
domain
Fibronectin type-III 12
1049
1190
domain
Tyrosine-protein phosphatase
1272
1527
glycosylation site
N-linked (GlcNAc...)
potential
75
75
glycosylation site
N-linked (GlcNAc...)
potential
106
106
glycosylation site
N-linked (GlcNAc...)
potential
128
128
glycosylation site
N-linked (GlcNAc...)
potential
169
169
glycosylation site
N-linked (GlcNAc...)
potential
212
212
glycosylation site
N-linked (GlcNAc...)
potential
229
229
glycosylation site
N-linked (GlcNAc...)
potential
259
259
glycosylation site
N-linked (GlcNAc...)
potential
289
289
glycosylation site
N-linked (GlcNAc...)
potential
317
317
glycosylation site
N-linked (GlcNAc...)
potential
471
471
glycosylation site
N-linked (GlcNAc...)
potential
486
486
glycosylation site
N-linked (GlcNAc...)
potential
512
512
glycosylation site
N-linked (GlcNAc...)
potential
533
533
glycosylation site
N-linked (GlcNAc...)
potential
588
588
glycosylation site
N-linked (GlcNAc...)
potential
668
668
glycosylation site
N-linked (GlcNAc...)
potential
687
687
glycosylation site
N-linked (GlcNAc...)
potential
719
719
glycosylation site
N-linked (GlcNAc...)
potential
723
723
glycosylation site
N-linked (GlcNAc...)
potential
823
823
glycosylation site
N-linked (GlcNAc...)
potential
841
841
glycosylation site
N-linked (GlcNAc...)
potential
874
874
glycosylation site
N-linked (GlcNAc...)
potential
908
908
glycosylation site
N-linked (GlcNAc...)
potential
925
925
glycosylation site
N-linked (GlcNAc...)
potential
1001
1001
glycosylation site
N-linked (GlcNAc...)
potential
1104
1104
glycosylation site
N-linked (GlcNAc...)
potential
1136
1136
glycosylation site
N-linked (GlcNAc...)
potential
1195
1195
active site
Phosphocysteine intermediate
by similarity
1468
1468
splice variant
(in isoform Short)
0
0
splice variant
(in isoform A)
0
0
splice variant
(in isoform Short)
1559
1631
SP Length
42
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
MLYQLSKATTRIRLKRQKAVPQHRWLWSLAFLAAFTLKDVRC
Sequence
MLYQLSKATTRIRLKRQKAVPQHRWLWSLAFLAAFTLKDVRC
ADLAISIP
NNPGLDDGASYRLDYSPPFGYPEP
N
TTIASREIGDEIQFSRALPGTKYNF
WLYYT
N
FTHHDWLTWTVTI
TTAPDPPS
N
LSVQVRSGKNAIILWSPPTQGS
YTAFKIKVLGLSEASSSY
N
RTFQVNDNTFQHSVKELTPGATYQVQAYTIY
DGKESVAYTSR
N
FT
TKPNTPGKFIVWFR
N
ETTLLVLWQPPYPAGIYTHYK
VSIEPPDA
N
DSVLYVEKEGEPPGPAQAAFKGLVPGRAY
N
ISVQTMSEDEI
SLPTTAQY
RTVPLRPL
N
VTFDRDFITSNSFRVLWEAPKGISEFDKYQVSV
ATTRRQSTVPRSNEPVAFFDFRDIAEPGKTFNVIVKTVSGKVTSWPATGD
VT
LRPLPVRNLRSINDDKTNTMIITWEADPASTQDEYRIVYHELETFNGD
TSTLTTDRTRFTLESLLPGR
N
YSLSVQAVSKKMES
N
ETSIFVV
TRPSSPI
IEDLKSIRMGL
N
ISWKSDVNSKQEQYEVLYSR
N
GTSDLRTQKTKESRLVI
KNLQPGAGYELKVFAVSHDLRSEPHAYFQA
VYPNPPR
N
MTIETVRSNSVL
VHWSPPESGEFTEYSIRYRTDSEQQWVRLPSVRSTEADITDMTKGEKYTI
QVNTVSFGVESPVPQEV
N
T
TVPPNPVSNIIQLVDSR
N
ITLEWPKPEGRVE
SYILKWWPSDNPGRVQTK
N
VSE
N
KSADDLSTVRVLIGELMPGVQYKFDIQ
TTSYGILSGITSLYPR
TMPLIQSDVVVANGEKEDERDTITLSYTPTPQSS
SKFDIYRFSLGDAEIRDKEKLA
N
DTDRKVTFTGLVPGRLY
N
ITVWTVSGG
VASLPIQRQDR
LYPEPITQLHAT
N
ITDTEISLRWDLPKGEYNDFDIAYLT
ADNLLAQ
N
MTTRNEITISDLRPHR
N
YTFTVVVRSGTESSVLRSSSPLSAS
FTTNE
AVPGRVERFHPTDVQPSEINFEWSLPSSEANGVIRQFSIAYTNIN
N
LTDAGMQDFESEEAFGVIKNLKPGETYVFKIQAKTAIGFGPEREYRQ
TM
PILAPPRPATQVVPTEVYRSSSTIQIRFRKNYFSDQNGQVRMYTIIVAED
DAK
N
ASGLEMPSWLDVQSYSVWLPYQAIDPYYPFE
N
RSVEDFTIGTENCD
NHKIGYCNGPLKSGTTYRVKVRAFTGADKFTDTAYSFPIQ
TDQD
N
TS
LIV
AITVPLTIILVLLVTLLF
YKRRRNNCRKTTKDSRANDNMSLPDSVIEQNR
PILIKNFAEHYRLMSADSDFR
FSEEFEELKHVGRDQPCTFADLPCNRPKN
RFTNILPYDHSRFKLQPVDDDEGSDYINANYVPGHNSPREFIVTQGPLHS
TRDDFWRMCWESNSRAIVMLTRCFEKGREKCDQYWPNDTVPVFYGDIKVQ
ILNDSHYADWVMTEFMLCRGSEQRILRHFHFTTWPDFGVPNPPQTLVRFV
RAFRDRIGAEQRPIVVH
C
SAGVGRSGTFITLDRILQQINTSDYVDIFGIV
YAMRKERVWMVQTEQQYICIHQCLLAV
LEGKENIVGPAREMHDNEGYEGQ
QVQLDENG
DVVATIEGHLSHHDLQQAEAEAIDDENAAILHDDQQPLTSSF
TGHHTHMPPTTSMSSFGGGGGGHTNVDAPDR
Original
MLYQLSKATTRIRLKRQKAVPQHRWLWSLAFLAAFTLKDVRCADLAISIP
NNPGLDDGASYRLDYSPPFGYPEPNTTIASREIGDEIQFSRALPGTKYNF
WLYYTNFTHHDWLTWTVTITTAPDPPSNLSVQVRSGKNAIILWSPPTQGS
YTAFKIKVLGLSEASSSYNRTFQVNDNTFQHSVKELTPGATYQVQAYTIY
DGKESVAYTSRNFTTKPNTPGKFIVWFRNETTLLVLWQPPYPAGIYTHYK
VSIEPPDANDSVLYVEKEGEPPGPAQAAFKGLVPGRAYNISVQTMSEDEI
SLPTTAQYRTVPLRPLNVTFDRDFITSNSFRVLWEAPKGISEFDKYQVSV
ATTRRQSTVPRSNEPVAFFDFRDIAEPGKTFNVIVKTVSGKVTSWPATGD
VTLRPLPVRNLRSINDDKTNTMIITWEADPASTQDEYRIVYHELETFNGD
TSTLTTDRTRFTLESLLPGRNYSLSVQAVSKKMESNETSIFVVTRPSSPI
IEDLKSIRMGLNISWKSDVNSKQEQYEVLYSRNGTSDLRTQKTKESRLVI
KNLQPGAGYELKVFAVSHDLRSEPHAYFQAVYPNPPRNMTIETVRSNSVL
VHWSPPESGEFTEYSIRYRTDSEQQWVRLPSVRSTEADITDMTKGEKYTI
QVNTVSFGVESPVPQEVNTTVPPNPVSNIIQLVDSRNITLEWPKPEGRVE
SYILKWWPSDNPGRVQTKNVSENKSADDLSTVRVLIGELMPGVQYKFDIQ
TTSYGILSGITSLYPRTMPLIQSDVVVANGEKEDERDTITLSYTPTPQSS
SKFDIYRFSLGDAEIRDKEKLANDTDRKVTFTGLVPGRLYNITVWTVSGG
VASLPIQRQDRLYPEPITQLHATNITDTEISLRWDLPKGEYNDFDIAYLT
ADNLLAQNMTTRNEITISDLRPHRNYTFTVVVRSGTESSVLRSSSPLSAS
FTTNEAVPGRVERFHPTDVQPSEINFEWSLPSSEANGVIRQFSIAYTNIN
NLTDAGMQDFESEEAFGVIKNLKPGETYVFKIQAKTAIGFGPEREYRQTM
PILAPPRPATQVVPTEVYRSSSTIQIRFRKNYFSDQNGQVRMYTIIVAED
DAKNASGLEMPSWLDVQSYSVWLPYQAIDPYYPFENRSVEDFTIGTENCD
NHKIGYCNGPLKSGTTYRVKVRAFTGADKFTDTAYSFPIQTDQDNTSLIV
AITVPLTIILVLLVTLLFYKRRRNNCRKTTKDSRANDNMSLPDSVIEQNR
PILIKNFAEHYRLMSADSDFRFSEEFEELKHVGRDQPCTFADLPCNRPKN
RFTNILPYDHSRFKLQPVDDDEGSDYINANYVPGHNSPREFIVTQGPLHS
TRDDFWRMCWESNSRAIVMLTRCFEKGREKCDQYWPNDTVPVFYGDIKVQ
ILNDSHYADWVMTEFMLCRGSEQRILRHFHFTTWPDFGVPNPPQTLVRFV
RAFRDRIGAEQRPIVVHCSAGVGRSGTFITLDRILQQINTSDYVDIFGIV
YAMRKERVWMVQTEQQYICIHQCLLAVLEGKENIVGPAREMHDNEGYEGQ
QVQLDENGDVVATIEGHLSHHDLQQAEAEAIDDENAAILHDDQQPLTSSF
TGHHTHMPPTTSMSSFGGGGGGHTNVDAPDR
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11